To kick off the project, Akimbo Health conducted thorough secondary research to identify and prioritize KOLs across key dimensions, such as specialty, influence, and geographic presence. This in-depth analysis allowed for a strategic segmentation of KOLs based on their characteristics and behaviors, ensuring the company’s efforts targeted the most impactful individuals.

Collaborative working sessions followed, during which Akimbo and the client co-developed an overarching engagement strategy. This plan outlined the optimal channels for interaction, linking them directly to the segmented KOL profiles.

With the strategy in place, Akimbo crafted a tactical engagement plan designed to drive meaningful interactions over time. The plan included a detailed schedule of activities, clearly defined internal ownership, and a prioritized target list of KOL participants. This ensured that every element of the engagement process was actionable, measurable, and aligned with the company’s launch objectives.

By the end of the engagement, the biotech company had a clear and actionable understanding of their KOL universe, complete with an effective segmentation and prioritization framework. They were fully aligned on a comprehensive engagement strategy and had a tactical roadmap ready for execution. These efforts positioned the company to build strong relationships with key influencers, paving the way for a successful launch and long-term market impact.